{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:39:51Z","timestamp":1771047591371,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.clinthera.2004.11.012","type":"journal-article","created":{"date-parts":[[2005,1,6]],"date-time":"2005-01-06T12:15:12Z","timestamp":1105013712000},"page":"1865-1873","source":"Crossref","is-referenced-by-count":26,"title":["Effects of tazarotene 0.1 % cream in the treatment of facial acnevulgaris: Pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials"],"prefix":"10.1016","volume":"26","author":[{"given":"Alan R","family":"Shalita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane S","family":"Berson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane M","family":"Thiboutot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J","family":"Leyden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dari","family":"Parizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Sefton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia S.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2004.11.012_bib1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199704173361607","article-title":"Therapy for acne vulgaris","volume":"336","author":"Leyden","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2004.11.012_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archderm.99.4.469","article-title":"Topical vitamin A acid in acne vulgaris","volume":"99","author":"Kligman","year":"1969","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clinthera.2004.11.012_bib3","first-page":"4","article-title":"Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: A randomized trial","volume":"67","author":"Webster","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.clinthera.2004.11.012_bib4","first-page":"4","article-title":"A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris","volume":"69","author":"Webster","year":"2002","journal-title":"Cutis"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2004.11.012_bib5","first-page":"12","article-title":"Once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.1% microsponge gel for the treatment of facial acne vulgaris: A double-blindrandomized trial","volume":"69","author":"Leyden","year":"2002","journal-title":"Cutis"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2004.11.012_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000211165","article-title":"Adapalene, a new chemical entity with retinoid activity","volume":"6","author":"Bernard","year":"1993","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.clinthera.2004.11.012_bib7","first-page":"349","article-title":"Tazarotene gel is safe and effective in the treatment of acne vulgaris: A multicenter, double-blind, vehicle-controlled study","volume":"63","author":"Shalita","year":"1999","journal-title":"Cutis"},{"key":"10.1016\/j.clinthera.2004.11.012_bib8","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/S0190-9622(97)70056-2","article-title":"Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials","volume":"36","author":"Cunliffe","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clinthera.2004.11.012_bib9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0190-9622(82)70063-5","article-title":"Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study","volume":"6","author":"Peck","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clinthera.2004.11.012_bib10","first-page":"773","article-title":"An ultrastmctural study of the effects of topical tretinoin on microcomedones","volume":"14","author":"Lavker","year":"1992","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2004.11.012_bib11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1067\/mjd.2003.103","article-title":"Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy oftazarotene creams 0.05% and 0.1% applied once daily for 12 weeks","volume":"48","author":"Weinstein","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clinthera.2004.11.012_bib12","series-title":"Biopharmaceutical Statistics for Drug Development","first-page":"403","article-title":"Clinical efficacy trials with categorical data","author":"Koch","year":"1988"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2004.11.012_bib13","first-page":"4","article-title":"Topical tazarotene in the treatment of facial acne vulgaris: The BEST (Balancing Efficacy, Speed, and Tolerability) in acne trial","volume":"74","author":"Shalita","year":"2004","journal-title":"Cutis"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2004.11.012_bib14","first-page":"9","article-title":"Meta-analysis of topical tazarotene in the treatment of mild to moderate acne","volume":"74","author":"Leyden","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.clinthera.2004.11.012_bib15","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0022-2275(20)42615-X","article-title":"Identification and quantitation of all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma","volume":"31","author":"Eckhoff","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinthera.2004.11.012_bib16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2165\/00003495-199753030-00003","article-title":"Current use and future potential role of retinoids in dermatology","volume":"53","author":"Orfanos","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2004.11.012_bib17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1074\/jbc.270.2.923","article-title":"Separation of transactivation and API antagonism functions of retinoic acid receptor alpha","volume":"270","author":"Nagpal","year":"1995","journal-title":"J Biol Chem"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0149291804803503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0149291804803503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T17:53:24Z","timestamp":1625334804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0149291804803503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["0149291804803503"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2004.11.012","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}